New Ray Medicine International Holding Ltd. (HK:6108) has released an update.
New Ray Medicine International Holding Ltd. has announced the composition of its board of directors and the roles within its four key committees, underscoring its commitment to strong corporate governance. The board is led by Executive Chairman and CEO Ms. Wang Qiuqin, with a balanced mix of executive and independent non-executive directors. These appointments reflect the company’s focus on strategic oversight and accountability.
For further insights into HK:6108 stock, check out TipRanks’ Stock Analysis page.